Pomegra
UnitedHealth (UNH) beat Q3 2026 earnings with $4.69 adjusted EPS and raised its full-year outlook to at least $20.50 per share, its third increase this year.
- Q3 adjusted EPS of $4.69 beat the $4.12 consensus and rose 60.6% from $2.92 a year earlier.
- 2026 adjusted EPS guidance is now at least $20.50, the third raise of the year.
- The medical care ratio improved 150 basis points to 88.4% as revenue slipped to $112.7 billion.
Lead
UnitedHealth Group (NYSE: UNH) reported third-quarter 2026 adjusted earnings of $4.69 per share on October 13, well above the $4.12 consensus estimate. Revenue of $112.7 billion also topped the $111.31 billion forecast, though it was down from $113.2 billion in the same quarter of 2025. The insurer lifted its 2026 adjusted EPS outlook to at least $20.50, the third increase this year. Shares rose 3.84% in premarket trading to $393.07 from a prior close of $378.52.What Did UnitedHealth Report for the Third Quarter?
UnitedHealth reported GAAP earnings of $4.56 per share and adjusted earnings of $4.69, against $2.59 and $2.92 in the third quarter of 2025. Earnings from operations rose 53% to $6.6 billion from $4.3 billion, and the net margin was 3.6%. Operating cash flow reached $5.1 billion, or 1.2 times net income. The debt-to-capital ratio stood at 41.7%.
The earnings beat came from cost control rather than growth. Revenue fell about 0.4% year over year, so the profit gain reflects margin recovery after a difficult 2025.
Why Did the Medical Care Ratio Matter So Much?
The medical care ratio matters because it measures the share of premiums paid out as medical claims, and it is the main driver of profit at a health insurer. UnitedHealth's ratio fell to 88.4% from 89.9% a year earlier. The company attributed the gain to medical cost management, pricing discipline, benefit design changes and care delivery enhancements.
Commercial medical costs remain elevated, with trends tracking above historical norms. Management also flagged arbitration costs under the No Surprises Act and uncertainty over Medicaid funding as continuing pressures.
How Did the Business Segments Perform?
Both operating units posted sharp profit gains on lower revenue. UnitedHealthcare, which serves 48.3 million members, generated $86.3 billion in revenue, down from $87.1 billion, and operating earnings of $2.8 billion, up from $1.8 billion. Medicare Advantage margins are expected near the top of the 2% to 4% range. Medicaid margins are expected to come in moderately better than negative 1% in 2026.
What Does the Third Guidance Raise Signal?
The raise to at least $20.50 per share signals that cost trends are stabilizing faster than the company projected earlier this year. Management described the figure as a solid run rate for future growth. It indicated that 2027 growth could land at the lower end of its long-term 13% to 16% range, a measured stance after the reset in 2025.
Chief Executive Stephen Hemsley said third-quarter results reflect the discipline and execution of the company's teams. The tone points to a margin-repair story rather than an expansion story, with membership and pricing choices still being used to protect profitability.
Market Reaction
The premarket gain left UnitedHealth shares well below their 52-week high of $461.62. The move reflects relief that the earnings recovery is tracking ahead of expectations. The EPS beat of nearly 14% was large for a company of this size, and the guidance raise removed some of the uncertainty that has weighed on managed care stocks.
Outlook
UnitedHealth enters the final quarter with a stronger margin base, a medical care ratio below 89% and a full-year EPS floor of $20.50. The main variables are commercial cost trends, Medicaid funding decisions and arbitration expenses. Segment targets, including Medicare Advantage margins near the top of their range and Optum Health's path to 6% to 8% by 2028, will define whether the recovery extends into 2027.
Mentioned tickers: UNH
